SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY DETECTION OF BRUCH MEMBRANE AND CHORIOCAPILLARIS ABNORMALITIES IN SORSBY MACULAR DYSTROPHY
暂无分享,去创建一个
P. Rosenfeld | B. Lam | Qinqin Zhang | Zhongdi Chu | G. Gregori | Hao Zhou | Yingying Shi | P. Iyer | O. Trivizki | Mengxi Shen | Ruikang K. Wang | Jeremy Liu | Giovanni Gregori
[1] Ruikang K. Wang,et al. An Update on the Hemodynamic Model of Age-Related Macular Degeneration. , 2021, American journal of ophthalmology.
[2] P. Charbel Issa,et al. Choriocapillaris Flow Signal Impairment in Sorsby Fundus Dystrophy , 2021, Ophthalmologica.
[3] P. Bartel,et al. Chromosome 10q26–driven age-related macular degeneration is associated with reduced levels of HTRA1 in human retinal pigment epithelium , 2021, Proceedings of the National Academy of Sciences.
[4] Ruikang K. Wang,et al. Guidelines for imaging the choriocapillaris using OCT angiography. , 2020, American journal of ophthalmology.
[5] Ruikang K. Wang,et al. Automated morphometric measurement of the retinal pigment epithelium complex and choriocapillaris using swept source OCT. , 2020, Biomedical optics express.
[6] Ruikang K Wang,et al. Improving visualization and quantitative assessment of choriocapillaris with swept source OCTA through registration and averaging applicable to clinical systems , 2018, Scientific Reports.
[7] Luis de Sisternes,et al. A Novel Strategy for Quantifying Choriocapillaris Flow Voids Using Swept-Source OCT Angiography , 2018, Investigative ophthalmology & visual science.
[8] D. Panagiotidis,et al. Choriocapillaris’ alterations in the presence of reticular pseudodrusen compared to drusen: study based on OCTA findings , 2018, International Ophthalmology.
[9] A. Lotery,et al. Long-term Outcome of Bevacizumab Therapy in Sorsby Fundus Dystrophy, A Case Series. , 2017 .
[10] Brian T. Soetikno,et al. Choriocapillaris Nonperfusion is Associated With Poor Visual Acuity in Eyes With Reticular Pseudodrusen. , 2017, American journal of ophthalmology.
[11] Joachim Hornegger,et al. TOWARD QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY: Visualizing Blood Flow Speeds in Ocular Pathology Using Variable Interscan Time Analysis , 2016, Retina.
[12] G. Ying,et al. Pseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials. , 2016, Ophthalmology.
[13] G. Giles,et al. Reticular Pseudodrusen and Their Association with Age-Related Macular Degeneration: The Melbourne Collaborative Cohort Study. , 2016, Ophthalmology.
[14] Joachim Hornegger,et al. TOWARD QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY: Visualizing Blood Flow Speeds in Ocular Pathology Using Variable Interscan Time Analysis. , 2016, Retina.
[15] Eric M. Moult,et al. Ultrahigh-Speed, Swept-Source Optical Coherence Tomography Angiography in Nonexudative Age-Related Macular Degeneration with Geographic Atrophy. , 2015, Ophthalmology.
[16] H. Stöhr,et al. Reticular Pseudodrusen in Sorsby Fundus Dystrophy. , 2015, Ophthalmology.
[17] P. Rosenfeld,et al. Widefield En Face Optical Coherence Tomography Imaging of Subretinal Drusenoid Deposits. , 2015, Ophthalmic surgery, lasers & imaging retina.
[18] H. Stöhr,et al. Sorsby Fundus Dystrophy: Novel Mutations, Novel Phenotypic Characteristics, and Treatment Outcomes. , 2015, Investigative ophthalmology & visual science.
[19] Ruikang K. Wang,et al. User-guided segmentation for volumetric retinal optical coherence tomography images. , 2014, Journal of biomedical optics.
[20] Ruikang K. Wang,et al. Depth-resolved imaging of capillary networks in retina and choroid using ultrahigh sensitive optical microangiography. , 2010, Optics letters.
[21] D. Edwards,et al. The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment. , 2010, Cancer letters.
[22] Ruikang K. Wang,et al. High-resolution wide-field imaging of retinal and choroidal blood perfusion with optical microangiography. , 2010, Journal of biomedical optics.
[23] N. Brown,et al. Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells. , 2005, Human molecular genetics.
[24] D. Edwards,et al. Metalloproteinases and their inhibitors in tumor angiogenesis , 2005, International journal of cancer.
[25] N. Ashton,et al. FUNDUS DYSTROPHY WITH UNUSUAL FEATURES* A HISTOLOGICAL STUDY , 2005 .
[26] Dao-Qiang Zhang,et al. A novel kernelized fuzzy C-means algorithm with application in medical image segmentation , 2004, Artif. Intell. Medicine.
[27] A. Bird,et al. TIMP-3 mRNA is not overexpressed in Sorsby fundus dystrophy. , 2003, American journal of ophthalmology.
[28] Masaru Miyagi,et al. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] A. Bird,et al. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. , 2000, Investigative ophthalmology & visual science.
[30] M. Kamei,et al. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. , 1999, Investigative ophthalmology & visual science.
[31] A. Eriksson,et al. Pseudoinflammatory fundus dystrophy: a follow‐up study , 1990, Clinical genetics.
[32] H. Morris,et al. Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). , 1990, The Biochemical journal.
[33] A. Bird,et al. Sorsby's fundus dystrophy. A light and electron microscopic study. , 1989, Ophthalmology.
[34] R. Dreyer,et al. Pseudoinflammatory macular dystrophy. , 1988, American journal of ophthalmology.
[35] A. Bird,et al. Sorsby's pseudoinflammatory macular dystrophy. , 1981, The British journal of ophthalmology.
[36] A. Sorsby,et al. A FUNDUS DYSTROPHY WITH UNUSUAL FEATURES (Late onset and dominant inheritance of a central retinal lesion showing oedema, haemorrhage and exudates developing into generalised choroidal atrophy with massive pigment proliferation) , 1949 .